For those that have been following our work, you will know that we like Gilead. They are an expert in solving health problems associated with viruses. There are many things in this world that puzzle us, but we do not understand why investors give more credence to a start-up looking for a Covis cure when there are proven drug development companies that get thrown over5board if not overlooked.
